Aster Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Aster Capital Management's VRTX Position: Q2 2026 in Review
Aster Capital Management opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 6,302 shares worth $3.13M. The stake represents 0.67% of the portfolio and ranks #25 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in VRTX as recently as Q3 2025.
Aster Capital Management first reported a position in VRTX in Q3 2024 and has held it in 4 quarters since. 1,749 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Aster Capital Management held 6,302 shares of Vertex Pharmaceuticals worth $3.13M as of Q2 2026.
- Vertex Pharmaceuticals was a new Aster Capital Management position in Q2 2026.
- Vertex Pharmaceuticals made up 0.67% of Aster Capital Management's portfolio in Q2 2026, its #25 holding.
- Aster Capital Management first reported a position in Vertex Pharmaceuticals in Q3 2024 and has held it in 4 quarters since.
- 1,749 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.